• About us
• Contact

Advertisement

Person › Details

Ingmar Hoerr (CureVac GmbH)

Hoerr, Ingmar (CureVac 201806– Chairman of Supervisory Board before 2000–201806 CEO + Co-Founder)

 

	Organisation	CureVac GmbH
	Today	CureVac AG
	Group	CureVac (Group)
	Product	therapeutic vaccine
	Product 2	RNA-based therapeutic

Record changed: 2022-11-18

Advertisement

More documents for Ingmar Hoerr

• [1] CureVac AG. (3/16/20). "Press Release: CureVac Announces Leadership Update". Tübingen & Boston, MA....
• [2] CureVac AG. (3/11/20). "Press Release: Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG". Tübingen & Boston, MA....
• [3] CureVac AG. (5/8/18). "Press Release: CureVac Announces New Management Structure. Founder Ingmar Hoerr to Transition to Chairman role; Daniel Menichella to Become CEO". Tübingen....
• [4] CureVac AG. (3/22/18). "Press Release: CureVac Receives U.S. Patent Covering Entire Process for Pharmaceutical Manufacturing of RNA". Tübingen & Boston, MA....
• [5] CureVac AG. (1/24/18). "Press Release: CureVac Expands Intellectual Property Position that Significantly Improves Protein Expression for its mRNA-Based Vaccines and Therapeutics". Tübingen....
• [6] CureVac AG. (1/4/18). "Press Release: CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-mediated mRNA Therapeutics". Tübingen, Boston, MA & San Diego, CA....
• [7] CureVac AG. (12/22/17). "Press Release: CureVac to Present at the 2018 J.P. Morgan 36th Annual Healthcare Conference". Tübingen & Boston, MA....
• [8] CureVac AG. (10/30/17). "Press Release: CureVac Announces Groundbreaking of Industrial-Scale GMP Production Facility for RNA Therapeutics". Tübingen....
• [9] CureVac AG. (10/18/17). "Press Release: Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines". Indianapolis, IN & Tübingen....
• [10] CureVac AG. (7/31/17). "Press Release: The 5th International mRNA Health Conference to Showcase Tremendous Advances in the Development of mRNA Drugs". Tübingen & Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.